Delpharm DIjon

Form 483 issued May 31, 2024 · Quetigny, France

Inspection
May 23 – May 31, 2024
Investigator
Jolanna A. Norton
Observations
2
Pages
2
FEI number
3014120699

In short: On May 31, 2024, FDA issued a Form 483 with 2 observations to Delpharm DIjon in Quetigny, France (FEI 3014120699) after an inspection that ran May 23 – May 31, 2024. The investigator was Jolanna A. Norton. Most observations concern production; the most-cited regulation is 21 CFR 211.186 (master production and control records).

At a glance

2 of 2 observations on this 483 concern production.

Production2

Most cited: 21 CFR 211.186 (1×) · 211.111 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The master production and control records are deficient in that they do not include a statement…

  2. 02

    Time limits are not established when appropriate for the completion of each production phase to assure…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Delpharm DIjon?

FDA listed 2 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.186 (master production and control records). The opening words of each observation are shown on this page.

Who inspected Delpharm DIjon?

Jolanna A. Norton is named on this Form 483, for the inspection of May 23 – May 31, 2024. Each investigator has a profile showing what they cite most.

When was Delpharm DIjon inspected by FDA?

The inspection ran May 23 – May 31, 2024, and the Form 483 is dated May 31, 2024.

How do I get the full Form 483 for Delpharm DIjon?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free